Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Gregson CL, Dennison EM, Compston JE, Adami S, Adachi JD, Anderson FA Jr, Boonen S, Chapurlat R, Díez-Pérez A, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Watts NB, Wyman A, Cooper C; GLOW Investigators. Gregson CL, et al. Among authors: roux c. Osteoporos Int. 2014 Jan;25(1):85-95. doi: 10.1007/s00198-013-2438-y. Epub 2013 Jul 25. Osteoporos Int. 2014. PMID: 23884437 Free PMC article.
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
Schnitzer T, Bone HG, Crepaldi G, Adami S, McClung M, Kiel D, Felsenberg D, Recker RR, Tonino RP, Roux C, Pinchera A, Foldes AJ, Greenspan SL, Levine MA, Emkey R, Santora AC 2nd, Kaur A, Thompson DE, Yates J, Orloff JJ. Schnitzer T, et al. Among authors: roux c. Aging (Milano). 2000 Feb;12(1):1-12. Aging (Milano). 2000. PMID: 10746426 Clinical Trial.
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.
Rizzoli R, Greenspan SL, Bone G 3rd, Schnitzer TJ, Watts NB, Adami S, Foldes AJ, Roux C, Levine MA, Uebelhart B, Santora AC 2nd, Kaur A, Peverly CA, Orloff JJ; Alendronate Once-Weekly Study Group. Rizzoli R, et al. Among authors: roux c. J Bone Miner Res. 2002 Nov;17(11):1988-96. doi: 10.1359/jbmr.2002.17.11.1988. J Bone Miner Res. 2002. PMID: 12412806 Free article. Clinical Trial.
Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis.
Delmas PD, Vrijens B, Eastell R, Roux C, Pols HA, Ringe JD, Grauer A, Cahall D, Watts NB; Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators. Delmas PD, et al. Among authors: roux c. J Clin Endocrinol Metab. 2007 Apr;92(4):1296-304. doi: 10.1210/jc.2006-1526. Epub 2007 Jan 23. J Clin Endocrinol Metab. 2007. PMID: 17244788 Clinical Trial.
Assessment of non-vertebral fracture risk in postmenopausal women.
Roux C, Briot K, Horlait S, Varbanov A, Watts NB, Boonen S. Roux C, et al. Ann Rheum Dis. 2007 Jul;66(7):931-5. doi: 10.1136/ard.2006.064071. Epub 2007 Feb 21. Ann Rheum Dis. 2007. PMID: 17314119 Free PMC article. Clinical Trial.
Effects of strontium ranelate on spinal osteoarthritis progression.
Bruyere O, Delferriere D, Roux C, Wark JD, Spector T, Devogelaer JP, Brixen K, Adami S, Fechtenbaum J, Kolta S, Reginster JY. Bruyere O, et al. Among authors: roux c. Ann Rheum Dis. 2008 Mar;67(3):335-9. doi: 10.1136/ard.2007.075572. Epub 2007 Oct 26. Ann Rheum Dis. 2008. PMID: 17965119 Free article. Clinical Trial.
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY. Meunier PJ, et al. Among authors: roux c. Osteoporos Int. 2009 Oct;20(10):1663-73. doi: 10.1007/s00198-008-0825-6. Epub 2009 Jan 20. Osteoporos Int. 2009. PMID: 19153678 Free PMC article. Clinical Trial.
2,126 results